SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001214659-18-000584
Filing Date
2018-01-22
Accepted
2018-01-22 18:00:28
Documents
2
Period of Report
2018-01-18

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT marketforms-40823.html 4  
1 PRIMARY DOCUMENT marketforms-40823.xml 4 3964
2 POA DOCUMENT poa.htm EX-24 3238
  Complete submission text file 0001214659-18-000584.txt   8612
Mailing Address C/O BIOMARIN PHARMACEUTICAL INC. 105 DIGITAL DRIVE NOVATO CA 94949
Business Address
FUCHS HENRY J (Reporting) CIK: 0001197355 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35921 | Film No.: 18540706

Mailing Address 9393 TOWNE CENTRE DRIVE SUITE 200 SAN DIEGO CA 92121
Business Address 9393 TOWNE CENTRE DRIVE SUITE 200 SAN DIEGO CA 92121 858-332-3410
Mirati Therapeutics, Inc. (Issuer) CIK: 0001576263 (see all company filings)

IRS No.: 462693615 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations